Phio Pharmaceuticals (PHIO) EBT Margin (QoQ) (2012 - 2018)
Phio Pharmaceuticals (PHIO) EBT Margin (QoQ) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 65,829.00 |
| Jun 30, 2018 | 645,720.00 |
| Mar 31, 2018 | 361,188.00 |
| Jun 30, 2016 | -226,778.00 |
| Mar 31, 2015 | 13.59 Mn |
| Dec 31, 2014 | -13.08 Mn |
| Sep 30, 2014 | 953,542.00 |
| Jun 30, 2014 | -551,695.00 |
| Mar 31, 2014 | -857,299.00 |
| Dec 31, 2013 | -700,064.00 |
| Sep 30, 2013 | -137,775.00 |
| Jun 30, 2013 | 4.89 Mn |
| Mar 31, 2013 | -4.55 Mn |
| Dec 31, 2012 | 42,725.00 |